ClearBridge Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

ClearBridge Investments’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,641	Closed	-$21K	–	1131
2019 Q1	$21K	Sell	1,641 -8	-0.5%	-$119	﹤0.01%	949
2018 Q4	$25K	Buy	1,649 +22	+1%	+$419	﹤0.01%	948
2018 Q3	$33K	Sell	1,627 -6	-0.4%	-$137	﹤0.01%	956
2018 Q2	$32K	Sell	1,633 -8	-0.5%	-$177	﹤0.01%	918
2018 Q1	$33K	Hold	1,641	–	–	﹤0.01%	906
2017 Q4	$22K	Buy	1,641 +7	+0.4%	+$106	﹤0.01%	989
2017 Q3	$30K	Buy	1,634 +49	+3%	+$913	﹤0.01%	981
2017 Q2	$29K	Buy	+1,585	New	+$31.4K	﹤0.01%	982

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ClearBridge Investments's AMAG Position: Q2 2019 in Review

ClearBridge Investments sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 1,641 shares — an estimated $21K sold.

ClearBridge Investments first reported a position in AMAG in Q2 2017 and held it in 8 quarters. The position peaked at $33K in Q3 2018. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

ClearBridge Investments reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
ClearBridge Investments sold 1,641 AMAG Pharmaceuticals shares in Q2 2019, an estimated $21K.
ClearBridge Investments first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 8 quarters.
ClearBridge Investments's AMAG Pharmaceuticals position peaked at $33K in Q3 2018.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on ClearBridge Investments's 13F filing for Q2 2019, filed 14 Aug 2019.